Research use only · Lyophilised material · Not a medicine · Not for human or veterinary use · Disclaimer
Sable Peptides

UK Research Peptide Market Statistics 2026

Each statistic is one sentence with a figure, a date and a source link. Catalogue figures are Sable's own published data. Publication and substance counts come from NCBI PubMed and PubChem. Research use only; not a medicine.

Last updated 10 October 2026

Catalogue and prices

  1. On 10 October 2026, the Sable Peptides price index covered 61 research compounds. Source: Sable Peptides, UK research peptide price index
  2. On 10 October 2026, the Sable Peptides price index covered 158 vial sizes. Source: Sable Peptides, UK research peptide price index
  3. On 10 October 2026, the Sable Peptides price index held 126 stored UK listings for like-for-like size checks. Source: Sable Peptides, UK research peptide price index
  4. On 10 October 2026, Sable catalogue vial prices ranged from £4.93 to £128.99. Source: Sable Peptides, UK peptide prices
  5. On 10 October 2026, the median Sable catalogue vial price was £24.98 across 158 vials. Source: Sable Peptides, UK peptide prices
  6. On 10 October 2026, the median Sable catalogue price per milligram was £2.80 across 157 vials stated in mg. Source: Sable Peptides, UK peptide prices
  7. On 10 October 2026, Sable catalogue prices per milligram ranged from £0.07 to £174.95. Source: Sable Peptides, UK peptide prices
  8. On 10 October 2026, 59 of 158 Sable catalogue vials were priced under £20. Source: Sable Peptides, UK peptide prices
  9. On 10 October 2026, 139 of 158 Sable catalogue vials were priced under £50. Source: Sable Peptides, UK peptide prices
  10. On 10 October 2026, 19 of the 61 compounds in the Sable catalogue were offered in three or more vial sizes. Source: Sable Peptides, UK peptide prices
  11. On 10 October 2026, Retatrutide was listed in 8 vial sizes in the Sable catalogue, from 5 mg to 60 mg. Source: Sable Peptides, UK peptide prices

Departments

  1. On 10 October 2026, the Short sequences department of the Sable catalogue listed 28 compounds. Source: Sable Peptides, Departments
  2. On 10 October 2026, the Repair department of the Sable catalogue listed 9 compounds. Source: Sable Peptides, Departments
  3. On 10 October 2026, the GH axis department of the Sable catalogue listed 8 compounds. Source: Sable Peptides, Departments
  4. On 10 October 2026, the Analogues department of the Sable catalogue listed 6 compounds. Source: Sable Peptides, Departments
  5. On 10 October 2026, the Blends department of the Sable catalogue listed 6 compounds. Source: Sable Peptides, Departments
  6. On 10 October 2026, the Other department of the Sable catalogue listed 4 compounds. Source: Sable Peptides, Departments

Reference data and site sections

  1. On 10 October 2026, the Sable reference index held 51 compound records with sourced facts. Source: Sable Peptides, UK Research Peptide Reference
  2. On 10 October 2026, 46 of 51 Sable reference records gave a sourced molecular weight. Source: Sable Peptides, UK Research Peptide Reference
  3. On 10 October 2026, 45 of 51 Sable reference records gave a sourced molecular formula. Source: Sable Peptides, UK Research Peptide Reference
  4. On 10 October 2026, 42 of 51 Sable reference records gave a CAS Registry Number. Source: Sable Peptides, UK Research Peptide Reference
  5. On 10 October 2026, Sable published 61 compound pages in its Learn section. Source: Sable Peptides, Learn
  6. On 10 October 2026, Sable published 12 plain-language notes in its Education section. Source: Sable Peptides, Education
  7. On 10 October 2026, the Sable glossary defined 15 catalogue terms. Source: Sable Peptides, Glossary
  8. On 10 October 2026, the Sable versus sitemap listed 1,830 compound comparison pages. Source: Sable Peptides, sitemap-versus.xml
  9. On 10 October 2026, the Sable locations index listed 2,182 UK places. Source: Sable Peptides, United Kingdom locations
  10. On 10 October 2026, the Sable locations index listed 1,666 UK towns. Source: Sable Peptides, United Kingdom locations
  11. On 10 October 2026, the Sable locations index listed 361 UK local authorities. Source: Sable Peptides, United Kingdom locations
  12. On 10 October 2026, the Sable locations index listed 115 UK postcode areas. Source: Sable Peptides, United Kingdom locations

PubChem

  1. On 10 October 2026, PubChem linked 59 depositor substance records (SIDs) to BPC-157 (CID 9941957). Source: PubChem (NCBI), PUG REST
  2. On 10 October 2026, PubChem linked 64 depositor substance records (SIDs) to Semaglutide (CID 56843331). Source: PubChem (NCBI), PUG REST
  3. On 10 October 2026, PubChem linked 17 depositor substance records (SIDs) to Tirzepatide (CID 166567236). Source: PubChem (NCBI), PUG REST
  4. On 10 October 2026, PubChem linked 73 depositor substance records (SIDs) to Ipamorelin (CID 9831659). Source: PubChem (NCBI), PUG REST
  5. On 10 October 2026, PubChem linked 44 depositor substance records (SIDs) to GHK-Cu (CID 71587328). Source: PubChem (NCBI), PUG REST
  6. On 10 October 2026, PubChem linked 88 depositor substance records (SIDs) to Epitalon (CID 219042). Source: PubChem (NCBI), PUG REST
  7. On 10 October 2026, PubChem linked 49 depositor substance records (SIDs) to Selank (CID 11765600). Source: PubChem (NCBI), PUG REST
  8. On 10 October 2026, PubChem linked 64 depositor substance records (SIDs) to Semax (CID 9811102). Source: PubChem (NCBI), PUG REST

PubMed

  1. PubMed indexed 16 records with a 2025 publication date that mention BPC-157 in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  2. PubMed indexed 1,674 records with a 2025 publication date that mention Semaglutide in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  3. PubMed indexed 904 records with a 2025 publication date that mention Tirzepatide in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  4. PubMed indexed 58 records with a 2025 publication date that mention Retatrutide in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  5. PubMed indexed 30 records with a 2025 publication date that mention Cagrilintide in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  6. PubMed indexed 0 records with a 2025 publication date that mention Ipamorelin in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  7. PubMed indexed 4 records with a 2025 publication date that mention Tesamorelin in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  8. PubMed indexed 5 records with a 2025 publication date that mention Epitalon in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  9. PubMed indexed 0 records with a 2025 publication date that mention Selank in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  10. PubMed indexed 8 records with a 2025 publication date that mention Semax in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  11. PubMed indexed 47 records with a 2025 publication date that mention MOTS-c in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  12. PubMed indexed 72 records with a 2025 publication date that mention SS-31 in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  13. PubMed indexed 17 records with a 2025 publication date that mention Thymosin beta-4 in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  14. PubMed indexed 8 records with a 2025 publication date that mention GHK-Cu in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  15. PubMed indexed 1 record with a 2025 publication date that mention KPV in the title or abstract (query run 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp])
  16. PubMed indexed 1,938 records with a 2026 publication date that mention Semaglutide in the title or abstract (year to date, as of 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp], year to date as of 10 Oct 2026)
  17. PubMed indexed 1,143 records with a 2026 publication date that mention Tirzepatide in the title or abstract (year to date, as of 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp], year to date as of 10 Oct 2026)
  18. PubMed indexed 89 records with a 2026 publication date that mention Retatrutide in the title or abstract (year to date, as of 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp], year to date as of 10 Oct 2026)
  19. PubMed indexed 28 records with a 2026 publication date that mention BPC-157 in the title or abstract (year to date, as of 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp], year to date as of 10 Oct 2026)
  20. PubMed indexed 49 records with a 2026 publication date that mention MOTS-c in the title or abstract (year to date, as of 10 October 2026). Source: PubMed (NCBI E-utilities esearch, publication date [dp], year to date as of 10 Oct 2026)

Download all statistics (CSV)

Cite this page

Sable Peptides. (2026, October 10). *UK research peptide market statistics 2026*. https://www.sablepeptides.co.uk/statistics
Sable Peptides (2026) *UK Research Peptide Market Statistics 2026*. Available at: https://www.sablepeptides.co.uk/statistics (Accessed: [date]).

Research use only. Not a medicine. Not for human or veterinary use.